The commercialization meeting of the IMCUSTOMEYE project took place in Madrid (Instituto de Óptica, CSIC) on November 2018 led by the partner IROC Science.
The IMCUSTOMEYE project will develop a new optical imaging system that will allow to obtain biomarkers to improve the diagnosis of a certain range of vision-threatening conditions. The main objective of the two day meeting was to establish new strategies for the development and commercialization of the Imcustomeye technologies defining their market perspective and potential applications. Each of the attending partners also gave an update on R&D status, which led to a product development roadmap.
The IMCUSTOMEYE consortium consists of 10 partners, from 6 different countries and different fields, academic, clinical and industrial. The attendees to the meeting were: IROC Science, CSIC, National University of Ireland, Polish Academy of Science, University of Liverpool, University College London, Oculus Gmbh, 2EyesVision SL and Optimo Medical AG.
Comments are closed.